Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16065871 | 1.00 | LMNA (0.32) | LMNACYP2C9 | |
| SCHEMBL2567708 | 0.97 | — | — | |
| SCHEMBL17338791 | 0.97 | — | — | |
| SCHEMBL17196020 | 0.97 | — | — | |
| SCHEMBL19976614 | 0.94 | LMNA (0.32) | LMNACYP2C9 | |
| SCHEMBL18769162 | 0.84 | — | — | |
| SCHEMBL14000270 | 0.82 | — | — | |
| SCHEMBL4096929 | 0.82 | — | — | |
| SCHEMBL14000168 | 0.82 | — | — | |
| SCHEMBL12918662 | 0.78 | MGAM (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713320-A2 | BCAT2 INHIBITORS | Agios Pharmaceuticals, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024238820-A2 | BCAT2 INHIBITORS | AGIOS PHARMACEUTICALS, INC. (US) | 2024-11-21 | — | — | WO | disclosed |
| EP-4430036-A2 | BCAT2 INHIBITORS | Agios Pharmaceuticals, Inc. (US) | 2024-09-18 | — | — | EP | disclosed |
| WO-2023086539-A2 | BCAT2 INHIBITORS | AGIOS PHARMACEUTICALS, INC. (US) | 2023-05-19 | — | — | WO | disclosed |